Jublia 10% topical solution 4ML
Ended Awarded Last action
- Contract number
- SPE2DR26FU423
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,309
Award facts
- Contract value 100% obligated
- $15,308.71 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $15,308.71 to AmerisourceBergen Drug Corp for Jublia 10% topical solution (4ml) on December 4, 2025, with completion scheduled for December 5, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to the major pharmaceutical distributor, with performance taking place at the company's corporate office in Conshohocken, Pennsylvania. The award is executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare systems worldwide.
AmerisourceBergen Drug Corp serves as a critical vendor within the Defense Health Agency's pharmaceutical supply chain, delivering specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The company's federal contract portfolio demonstrates extensive experience fulfilling diverse medical procurement requirements through competitive awards with firm fixed pricing structures. As a major healthcare solutions provider and pharmaceutical distributor, AmerisourceBergen maintains significant capacity to support military and veteran healthcare systems, positioning it as a key supplier within the DLA's medical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DR26FU423?
SPE2DR26FU423 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 4, 2025.
How much is contract SPE2DR26FU423 worth?
The government has obligated $15,309 on SPE2DR26FU423.
Is contract SPE2DR26FU423 an order under another contract?
Yes. SPE2DR26FU423 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FU423 competed?
The extent of competition for SPE2DR26FU423 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award